Long-term outcome and health-related quality of life in benign paroxysmal positional vertigo.
Identifieur interne : 000341 ( Main/Corpus ); précédent : 000340; suivant : 000342Long-term outcome and health-related quality of life in benign paroxysmal positional vertigo.
Auteurs : Jose A. Lopez-Escamez ; Maria J. Gamiz ; Antonio Fernandez-Perez ; Manuel Gomez-Fi AnaSource :
- European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery [ 0937-4477 ] ; 2005.
English descriptors
- KwdEn :
- Cohort Studies (MeSH), Female (MeSH), Follow-Up Studies (MeSH), Humans (MeSH), Male (MeSH), Middle Aged (MeSH), Posture (MeSH), Prospective Studies (MeSH), Quality of Life (MeSH), Semicircular Canals (physiopathology), Severity of Illness Index (MeSH), Surveys and Questionnaires (MeSH), Treatment Outcome (MeSH), Vertigo (psychology), Vertigo (therapy).
- MESH :
- physiopathology : Semicircular Canals.
- psychology : Vertigo.
- therapy : Vertigo.
- Cohort Studies, Female, Follow-Up Studies, Humans, Male, Middle Aged, Posture, Prospective Studies, Quality of Life, Severity of Illness Index, Surveys and Questionnaires, Treatment Outcome.
Abstract
A prospective cohort study was designed to evaluate the long-term outcome and health-related quality of life (HRQoL) in patients with posterior canal benign paroxysmal positional vertigo (PC-BPPV) treated by the particle repositioning maneuver (PRM) in the outpatient clinic of a general community hospital. Fifty individuals with PC-BPPV were included, and 45 (90%) completed the study. The diagnosis was based on the history of short episodes of vertigo and a positional nystagmus during the Dix-Hallpike test (DHT). All patients were treated by a single PRM, and relapses were evaluated by DHT at 30, 180 and 360 days post-treatment; a new PRM was performed if the DHT was positive. The main outcome measures were: percentage of patients with a negative DHT after treatment, scores obtained on the Medical Outcomes Study 36-Item Short Form Health Survey (SF-36) and the Dizziness Handicap Inventory Short Form (DHI-S) before and 30, 180 and 360 days post-treatment. The DHT was found negative in 80% (40/50) of individuals at 30 days. Ten, seven and five patients presented a positive DHT at 30, 180 and 360 days, respectively. Persistent BPPV was observed in 5% (2/50) of patients at 360 days, despite repeated PRM. Relapses (DH+ after successful PRM) were observed in 7.5% (3/50) at 180 days and 360 days. Both questionnaires showed a reliability Cronbach's alpha >0.7. The average standardized score for each SF-36 scale was compared with the reference population normative data, showing differences with norms for all scales except for vitality. After PRM, patients improved their scores with both instruments, indicating a restoration of HRQoL at 30 days. Physical dimension scores of the SF-36 improved from day 30 to 360. DHI-S scores were statistically better after PRM (P < 0.001). Our results show that the effectiveness of PRM is 88% after 1 year of follow-up. Patients with BPPV experienced a decrease in HRQoL, which was restored after PRM. Although relapses were observed in 7.5% of individuals, they did not affect HRQoL.
DOI: 10.1007/s00405-004-0841-x
PubMed: 15942805
Links to Exploration step
pubmed:15942805Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Long-term outcome and health-related quality of life in benign paroxysmal positional vertigo.</title>
<author><name sortKey="Lopez Escamez, Jose A" sort="Lopez Escamez, Jose A" uniqKey="Lopez Escamez J" first="Jose A" last="Lopez-Escamez">Jose A. Lopez-Escamez</name>
<affiliation><nlm:affiliation>Otology and Neurotology Group CTS495 of the Department of Surgery, Hospital de Poniente, Almería, Spain. jalopeze@cajamar.es</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Gamiz, Maria J" sort="Gamiz, Maria J" uniqKey="Gamiz M" first="Maria J" last="Gamiz">Maria J. Gamiz</name>
</author>
<author><name sortKey="Fernandez Perez, Antonio" sort="Fernandez Perez, Antonio" uniqKey="Fernandez Perez A" first="Antonio" last="Fernandez-Perez">Antonio Fernandez-Perez</name>
</author>
<author><name sortKey="Gomez Fi Ana, Manuel" sort="Gomez Fi Ana, Manuel" uniqKey="Gomez Fi Ana M" first="Manuel" last="Gomez-Fi Ana">Manuel Gomez-Fi Ana</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2005">2005</date>
<idno type="RBID">pubmed:15942805</idno>
<idno type="pmid">15942805</idno>
<idno type="doi">10.1007/s00405-004-0841-x</idno>
<idno type="wicri:Area/Main/Corpus">000341</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000341</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Long-term outcome and health-related quality of life in benign paroxysmal positional vertigo.</title>
<author><name sortKey="Lopez Escamez, Jose A" sort="Lopez Escamez, Jose A" uniqKey="Lopez Escamez J" first="Jose A" last="Lopez-Escamez">Jose A. Lopez-Escamez</name>
<affiliation><nlm:affiliation>Otology and Neurotology Group CTS495 of the Department of Surgery, Hospital de Poniente, Almería, Spain. jalopeze@cajamar.es</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Gamiz, Maria J" sort="Gamiz, Maria J" uniqKey="Gamiz M" first="Maria J" last="Gamiz">Maria J. Gamiz</name>
</author>
<author><name sortKey="Fernandez Perez, Antonio" sort="Fernandez Perez, Antonio" uniqKey="Fernandez Perez A" first="Antonio" last="Fernandez-Perez">Antonio Fernandez-Perez</name>
</author>
<author><name sortKey="Gomez Fi Ana, Manuel" sort="Gomez Fi Ana, Manuel" uniqKey="Gomez Fi Ana M" first="Manuel" last="Gomez-Fi Ana">Manuel Gomez-Fi Ana</name>
</author>
</analytic>
<series><title level="j">European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery</title>
<idno type="ISSN">0937-4477</idno>
<imprint><date when="2005" type="published">2005</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Cohort Studies (MeSH)</term>
<term>Female (MeSH)</term>
<term>Follow-Up Studies (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Male (MeSH)</term>
<term>Middle Aged (MeSH)</term>
<term>Posture (MeSH)</term>
<term>Prospective Studies (MeSH)</term>
<term>Quality of Life (MeSH)</term>
<term>Semicircular Canals (physiopathology)</term>
<term>Severity of Illness Index (MeSH)</term>
<term>Surveys and Questionnaires (MeSH)</term>
<term>Treatment Outcome (MeSH)</term>
<term>Vertigo (psychology)</term>
<term>Vertigo (therapy)</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Semicircular Canals</term>
</keywords>
<keywords scheme="MESH" qualifier="psychology" xml:lang="en"><term>Vertigo</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Vertigo</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Cohort Studies</term>
<term>Female</term>
<term>Follow-Up Studies</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Posture</term>
<term>Prospective Studies</term>
<term>Quality of Life</term>
<term>Severity of Illness Index</term>
<term>Surveys and Questionnaires</term>
<term>Treatment Outcome</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">A prospective cohort study was designed to evaluate the long-term outcome and health-related quality of life (HRQoL) in patients with posterior canal benign paroxysmal positional vertigo (PC-BPPV) treated by the particle repositioning maneuver (PRM) in the outpatient clinic of a general community hospital. Fifty individuals with PC-BPPV were included, and 45 (90%) completed the study. The diagnosis was based on the history of short episodes of vertigo and a positional nystagmus during the Dix-Hallpike test (DHT). All patients were treated by a single PRM, and relapses were evaluated by DHT at 30, 180 and 360 days post-treatment; a new PRM was performed if the DHT was positive. The main outcome measures were: percentage of patients with a negative DHT after treatment, scores obtained on the Medical Outcomes Study 36-Item Short Form Health Survey (SF-36) and the Dizziness Handicap Inventory Short Form (DHI-S) before and 30, 180 and 360 days post-treatment. The DHT was found negative in 80% (40/50) of individuals at 30 days. Ten, seven and five patients presented a positive DHT at 30, 180 and 360 days, respectively. Persistent BPPV was observed in 5% (2/50) of patients at 360 days, despite repeated PRM. Relapses (DH+ after successful PRM) were observed in 7.5% (3/50) at 180 days and 360 days. Both questionnaires showed a reliability Cronbach's alpha >0.7. The average standardized score for each SF-36 scale was compared with the reference population normative data, showing differences with norms for all scales except for vitality. After PRM, patients improved their scores with both instruments, indicating a restoration of HRQoL at 30 days. Physical dimension scores of the SF-36 improved from day 30 to 360. DHI-S scores were statistically better after PRM (P < 0.001). Our results show that the effectiveness of PRM is 88% after 1 year of follow-up. Patients with BPPV experienced a decrease in HRQoL, which was restored after PRM. Although relapses were observed in 7.5% of individuals, they did not affect HRQoL.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">15942805</PMID>
<DateCompleted><Year>2006</Year>
<Month>07</Month>
<Day>18</Day>
</DateCompleted>
<DateRevised><Year>2018</Year>
<Month>11</Month>
<Day>13</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0937-4477</ISSN>
<JournalIssue CitedMedium="Print"><Volume>262</Volume>
<Issue>6</Issue>
<PubDate><Year>2005</Year>
<Month>Jun</Month>
</PubDate>
</JournalIssue>
<Title>European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery</Title>
<ISOAbbreviation>Eur Arch Otorhinolaryngol</ISOAbbreviation>
</Journal>
<ArticleTitle>Long-term outcome and health-related quality of life in benign paroxysmal positional vertigo.</ArticleTitle>
<Pagination><MedlinePgn>507-11</MedlinePgn>
</Pagination>
<Abstract><AbstractText>A prospective cohort study was designed to evaluate the long-term outcome and health-related quality of life (HRQoL) in patients with posterior canal benign paroxysmal positional vertigo (PC-BPPV) treated by the particle repositioning maneuver (PRM) in the outpatient clinic of a general community hospital. Fifty individuals with PC-BPPV were included, and 45 (90%) completed the study. The diagnosis was based on the history of short episodes of vertigo and a positional nystagmus during the Dix-Hallpike test (DHT). All patients were treated by a single PRM, and relapses were evaluated by DHT at 30, 180 and 360 days post-treatment; a new PRM was performed if the DHT was positive. The main outcome measures were: percentage of patients with a negative DHT after treatment, scores obtained on the Medical Outcomes Study 36-Item Short Form Health Survey (SF-36) and the Dizziness Handicap Inventory Short Form (DHI-S) before and 30, 180 and 360 days post-treatment. The DHT was found negative in 80% (40/50) of individuals at 30 days. Ten, seven and five patients presented a positive DHT at 30, 180 and 360 days, respectively. Persistent BPPV was observed in 5% (2/50) of patients at 360 days, despite repeated PRM. Relapses (DH+ after successful PRM) were observed in 7.5% (3/50) at 180 days and 360 days. Both questionnaires showed a reliability Cronbach's alpha >0.7. The average standardized score for each SF-36 scale was compared with the reference population normative data, showing differences with norms for all scales except for vitality. After PRM, patients improved their scores with both instruments, indicating a restoration of HRQoL at 30 days. Physical dimension scores of the SF-36 improved from day 30 to 360. DHI-S scores were statistically better after PRM (P < 0.001). Our results show that the effectiveness of PRM is 88% after 1 year of follow-up. Patients with BPPV experienced a decrease in HRQoL, which was restored after PRM. Although relapses were observed in 7.5% of individuals, they did not affect HRQoL.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lopez-Escamez</LastName>
<ForeName>Jose A</ForeName>
<Initials>JA</Initials>
<AffiliationInfo><Affiliation>Otology and Neurotology Group CTS495 of the Department of Surgery, Hospital de Poniente, Almería, Spain. jalopeze@cajamar.es</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Gamiz</LastName>
<ForeName>Maria J</ForeName>
<Initials>MJ</Initials>
</Author>
<Author ValidYN="Y"><LastName>Fernandez-Perez</LastName>
<ForeName>Antonio</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y"><LastName>Gomez-Fiñana</LastName>
<ForeName>Manuel</ForeName>
<Initials>M</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2004</Year>
<Month>11</Month>
<Day>16</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>Germany</Country>
<MedlineTA>Eur Arch Otorhinolaryngol</MedlineTA>
<NlmUniqueID>9002937</NlmUniqueID>
<ISSNLinking>0937-4477</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011187" MajorTopicYN="N">Posture</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011788" MajorTopicYN="Y">Quality of Life</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012665" MajorTopicYN="N">Semicircular Canals</DescriptorName>
<QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014717" MajorTopicYN="N">Vertigo</DescriptorName>
<QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2004</Year>
<Month>04</Month>
<Day>29</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2004</Year>
<Month>07</Month>
<Day>08</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2005</Year>
<Month>6</Month>
<Day>9</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2006</Year>
<Month>7</Month>
<Day>19</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2005</Year>
<Month>6</Month>
<Day>9</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">15942805</ArticleId>
<ArticleId IdType="doi">10.1007/s00405-004-0841-x</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Am J Otol. 1998 Nov;19(6):804-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9831158</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Phys Ther. 1997 Jun;77(6):602-18</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9184686</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Clin Epidemiol. 1998 Nov;51(11):1087-94</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9817126</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Otolaryngol Head Neck Surg. 2000 May;122(5):647-52</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10793340</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Mayo Clin Proc. 2000 Jul;75(7):695-700</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10907384</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Med Care. 1992 Jun;30(6):473-83</Citation>
<ArticleIdList><ArticleId IdType="pubmed">1593914</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Otol Neurotol. 2002 Nov;23(6):926-32</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12438857</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Arch Otolaryngol Head Neck Surg. 1990 Apr;116(4):424-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2317323</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Otolaryngol Head Neck Surg. 1992 Sep;107(3):399-404</Citation>
<ArticleIdList><ArticleId IdType="pubmed">1408225</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Otol Neurotol. 2002 Jan;23(1):79-83</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11773852</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Neurology. 2003 May 13;60(9):1532-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12743247</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Laryngoscope. 2000 Apr;110(4):655-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10764014</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Laryngoscope. 2000 Aug;110(8):1385-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10942146</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Otol Neurotol. 2003 Jul;24(4):637-41</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12851558</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Ann Otol Rhinol Laryngol. 1993 May;102(5):325-31</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8489160</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Otolaryngol Head Neck Surg. 1995 Dec;113(6):712-20</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7501382</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Ann Otol Rhinol Laryngol. 1952 Dec;61(4):987-1016</Citation>
<ArticleIdList><ArticleId IdType="pubmed">13008328</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cochrane Database Syst Rev. 2002;(1):CD003162</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11869655</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Otolaryngol. 1979 Fall;1(1):1-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">552801</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Otolaryngol. 2000 Feb;29(1):2-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10709164</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TestDixHallpikeV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000341 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 000341 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= TestDixHallpikeV1 |flux= Main |étape= Corpus |type= RBID |clé= pubmed:15942805 |texte= Long-term outcome and health-related quality of life in benign paroxysmal positional vertigo. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i -Sk "pubmed:15942805" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd \ | NlmPubMed2Wicri -a TestDixHallpikeV1
![]() | This area was generated with Dilib version V0.6.37. | ![]() |